The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms.
about
The Crystal Structure of Human Soluble CD14 Reveals a Bent Solenoid with a Hydrophobic Amino-Terminal PocketThe involvement of CD14 in the activation of human monocytes by peptidoglycan monomersSurfactant Proteins A and D Bind CD14 by Different MechanismsExpression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia.N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.Clinical proteomics identifies urinary CD14 as a potential biomarker for diagnosis of stable coronary artery diseaseSoluble CD14 is a nonspecific marker of monocyte activation.Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14.Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals.Rhizobium leguminosarum chaperonin 60.3, but not chaperonin 60.1, induces cytokine production by human monocytes: activity is dependent on interaction with cell surface CD14.Rat mannose-binding protein a binds CD14.Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14.Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes.
P2860
Q27675591-082D2E8F-C9AB-4569-B96E-CF1928461F04Q28350221-FC164F0E-65E9-4A8B-9ED6-B3F76B0BCCB3Q29392656-6258DAEB-D167-46D6-BC32-9474CDBFCA43Q33753479-875D76E1-2131-4704-AC05-1AD52A7C63DBQ33767236-96C76B97-B6CF-4822-B837-C02652D3E928Q33946526-7BBE2069-DFE5-4BAB-86A0-0DE37991A7EBQ34005092-28DF7603-B393-4B8B-B77A-861445FCDC78Q34229777-42208D84-22DD-419C-A861-FB192B3740A8Q35558889-1A539E2A-FBA2-4527-9F7E-C46F4CE715FDQ35676127-330FF635-F90C-4FD9-9468-CA9C2CD73859Q36622053-7DEB3AC9-DD70-465A-80D1-559AD958763DQ36661493-956BB12A-6F9E-4469-8A5C-095FB4D3ED6AQ37490068-CBDDCCFD-A139-42B7-B137-F02DD0F9D911Q39518798-C5AABEBB-9729-45A3-A08D-95ECE14DDC56Q39572778-FFF08C3A-9895-4D78-B516-C9A96477F511Q39829172-E4E13B01-1ABF-4401-A463-50E5EEE167F4
P2860
The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The myeloid differentiation an ...... fferent soluble CD14 isoforms.
@en
type
label
The myeloid differentiation an ...... fferent soluble CD14 isoforms.
@en
prefLabel
The myeloid differentiation an ...... fferent soluble CD14 isoforms.
@en
P2093
P2860
P1433
P1476
The myeloid differentiation an ...... ifferent soluble CD14 isoforms
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1996.00457.X
P407
P577
1996-03-01T00:00:00Z